Wellness Wire Kansas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Wire Kansas.

Press releases published on September 30, 2026

21 minutes ago

SK pharmteco Announces $200-Plus Million U.S. Investment to Expand Small Molecule and Peptide Capacity

Indeterminate GlobeNewswire

22 minutes ago

CJ Biomaterials Secures BPI, TÜV AUSTRIA Certifications for New PHACT™ All-PHA Compound Designed for Home Compostable Cutlery

Indeterminate GlobeNewswire

25 minutes ago

Allarity Provides Update on Key Recent Advances Solidifying Drug Response Predictor® to Drive Stenoparib’s Clinical Development

Indeterminate GlobeNewswire

25 minutes ago

HealthEquity Appoints Moody’s CFO Noémie Heuland to Board of Directors

Indeterminate GlobeNewswire

25 minutes ago

Highlight Therapeutics Presents Positive Phase 2b Topline Results of Intralesional BO-112 in Localized Basal Cell Carcinoma as a Late-Breaker at EADV

Indeterminate GlobeNewswire

25 minutes ago

Hyperion DeFi, Anchorage Digital, and HyperLend Together Announce the First Institutional Credit Facility on Hyperliquid

Indeterminate GlobeNewswire

30 minutes ago

OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution

Indeterminate GlobeNewswire

35 minutes ago

Silo Pharma’s QwikAgents Expands AI Agent Platform with NVIDIA Model Support and New Runtime Flexibility

Indeterminate GlobeNewswire

40 minutes ago

Avaí Bio and Austrianova Successfully Encapsulate GMP-Quality Klotho-Producing Cells, Achieve Robust Klotho Secretion

Indeterminate GlobeNewswire

41 minutes ago

AIM ImmunoTech Discusses Ampligen®’s Potential to Complement Emerging Pancreatic Cancer Therapies in New CEO Corner Video

Indeterminate GlobeNewswire

an hour ago

Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND

Indeterminate GlobeNewswire

an hour ago

Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance

Indeterminate GlobeNewswire

an hour ago

Candel Therapeutics Announces Integrated Clinical and Biomarker Data That Showed Durable Local and Systemic Immune Activation after Aglatimagene Besadenovec in Intermediate-Risk Localized Prostate Cancer

Indeterminate GlobeNewswire

an hour ago

Project MEND Uses SteraMist to Safely Disinfect Medical Equipment for Reuse

Indeterminate GlobeNewswire

an hour ago

Decoy Therapeutics to Present at The Small Cap Showcase

Indeterminate GlobeNewswire

an hour ago

Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18)

Indeterminate GlobeNewswire

an hour ago

Candel Therapeutics Announces New Data Showing Sustained Immune Remodeling More Than Two Years After Aglatimagene Besadenovec Treatment in Localized Prostate Cancer at ASTRO 2026

Indeterminate GlobeNewswire

an hour ago

Ardelyx Earns Multiple Honors at the 2026 PM360 Trailblazer Awards

Indeterminate GlobeNewswire

an hour ago

Silexion Therapeutics Announces First Patient Successfully Dosed in Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

Indeterminate GlobeNewswire

an hour ago

DiFusion Activates Operating Board to Scale Therapeutic Biomaterials Platform

Indeterminate GlobeNewswire